Safety & Toxicology
Phenibut Safety, Toxicology & Hazard Information
This page summarizes publicly documented hazard and toxicology information for phenibut, for the safe handling and responsible distribution of the material as a laboratory research chemical. It reinforces that the material must not be ingested and is not for human or animal consumption. It is hazard-communication reference — not dosage, medical, or usage guidance.
No established human lethal dose
The authoritative public literature does not establish a validated human lethal dose, minimum lethal dose, or “fatal amount” for phenibut. Poison-center death reports generally lack verified product concentration or controlled-exposure data, and forensic cases frequently involve co-exposures and causation uncertainty. For that reason a responsible research-chemical label should state that no established human lethal dose is known rather than print a numeric figure, which could create a false safety boundary.
Documented hazards (as warnings)
Across U.S. poison-center surveillance, the World Health Organization’s Expert Committee review, and clinical toxicology sources, phenibut exposure has been associated with a serious hazard profile, including:
- Severe sedation, drowsiness, and decreased consciousness
- Respiratory depression
- Agitation, confusion, hallucinations, and delirium
- Seizures
- Stupor and coma
- Physical dependence and a dangerous, potentially life-threatening withdrawal syndrome
- Death (reported in surveillance and forensic sources)
These are presented as hazard warnings that underscore why the material must not be consumed — not as a description of any intended effect.
Public-source evidence
- U.S. poison centers (CDC/MMWR, 2009–2019): a national analysis recorded 1,320 phenibut exposures, with roughly 12.6% involving major/life-threatening outcomes and three reported deaths; co-ingestants were common. These surveillance reports were generally not laboratory-confirmed and do not establish a dose threshold.
- WHO Expert Committee on Drug Dependence (44th ECDD pre-review, 2021): concluded phenibut toxicity is highly variable, noted the limitations of an old animal LD50 figure (an intraperitoneal mouse value whose original study could not be identified), and cautioned that routine screening for phenibut is not readily available. An animal value must not be converted into a human lethal dose.
- Poison Control (U.S.): documents severe central-nervous-system effects and interaction hazards, and provides the U.S. emergency number below.
Interaction hazard
Documented poisonings frequently involve more than one substance. As a hazard warning: phenibut exposure has been associated with dangerous additive effects when combined with alcohol, opioids, benzodiazepine-type sedatives, and other central-nervous-system depressants, increasing the risk of severe sedation or coma. The material must not be combined with anything intended for human consumption.
Laboratory handling & emergency information
- Handle only with appropriate PPE (gloves, eye protection, lab coat); avoid generating or inhaling dust; avoid eye and skin contact.
- Keep the container tightly closed; store in a secure, dry location, away from children and away from any consumables.
- There is no established phenibut-specific antidote; documented clinical management is supportive.
- If swallowed, or if severe symptoms occur, seek medical attention immediately. U.S. Poison Control: 1-800-222-1222. Call emergency services for severe breathing difficulty, unresponsiveness, seizure, or severe delirium.
Why we do not publish a “lethal dose” number
Because product purity varies, exposure histories can be inaccurate, co-ingestants are common, individual susceptibility differs, and phenibut is often not detected by routine clinical screens, the evidence base is structurally incapable of producing a reliable human lethal figure. Printing one would imply a precision the science does not possess and could dangerously imply that lower amounts are safe. See our regulatory status and Safety Data Sheets pages.
Authoritative references
- FDA — Phenibut in Dietary Supplements (agency position and enforcement history).
- CDC/MMWR, Vol. 69 — Phenibut Exposures Reported to Poison Centers, United States, 2009–2019.
- WHO Expert Committee on Drug Dependence (44th ECDD) — Phenibut pre-review report.
- U.S. Poison Control — Phenibut.
- PubChem — Phenibut (CID 14113).
Availability is not safety
The fact that a substance can be obtained without a prescription, or is not scheduled in a given place, does not mean it is safe. Documented dependence, a dangerous withdrawal syndrome, and severe toxicity are all recorded for phenibut regardless of its legal availability. Online community and forum “harm-reduction” rules (use frequencies, self-imposed caps, and the like) are not validated and are documented to fail; they must not be relied upon as safety guidance. This material is for laboratory research only and is not for human or animal consumption.
For Research Use Only. Not for human or animal consumption. Do not ingest. This page is hazard, safety, and regulatory reference information for handling a laboratory research material. It is not medical advice, dosage guidance, or usage instruction of any kind. No statement here has been evaluated by the U.S. FDA. See our Disclaimer.